Outcomes

The evidence for testosterone enanthate outcomes comes primarily from specialized clinical populations, with limited data from large-scale randomized controlled trials.

Pediatric and Adolescent Populations

Constitutional Delay of Growth and Puberty: A systematic review and meta-analysis found that testosterone therapy improved growth parameters and pubertal development in boys with constitutional delay, though the review notes this was exploratory in nature and effect sizes were not consistently reported across studies.

Delayed Puberty and Wellbeing: One study reported that low-dose testosterone treatment improved wellbeing and emotional state in boys with self-limited delayed puberty, though specific validated outcome measures and effect magnitudes were not detailed in the available evidence.

Hypospadias Repair: Research examined testosterone's role in reducing urethrocutaneous fistula formation after hypospadias surgery, though outcomes data from this study were not provided in the available abstracts.

Adult Male Hypogonadism

Body Composition: A study investigating testosterone replacement therapy combined with exercise in hypogonadal men reported improvements in body composition, though specific metrics (lean mass changes, fat mass reduction) and statistical significance were not detailed in the available evidence.

Cancer-Related Fatigue: A completed Phase 3 trial examined testosterone replacement for fatigue in male hypogonadal advanced cancer patients, but outcome results were not available in the provided evidence.

Specialized Conditions

Micropenis in Androgen Insensitivity: A case report documented testosterone treatment outcomes for micropenis in partial androgen insensitivity syndrome, though measurable results were not specified.

Spinal Cord Injury: An ongoing Phase 2 trial is investigating testosterone with locomotor training for bone and muscle health after spinal cord injury, but results are not yet available.

Evidence Limitations

The available evidence is notably limited in providing specific outcome measures, effect sizes, or statistical significance data. Most studies appear to be small-scale or case reports rather than large randomized controlled trials. The evidence base would benefit from more robust clinical trial data with clearly defined primary endpoints and validated outcome measures.

This information is for educational purposes only and should not replace consultation with a healthcare provider for individual medical decisions.

Testosterone Enanthate

Member access required